WADDELL & REED FINANCIAL INC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 159 filers reported holding PTC THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
WADDELL & REED FINANCIAL INC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$5,912,000
+597.2%
116,518
-11.5%
0.02%
+650.0%
Q1 2016$848,000
-98.6%
131,684
-92.9%
0.00%
-97.9%
Q4 2015$60,076,000
+25.5%
1,854,184
+3.4%
0.10%
+22.8%
Q3 2015$47,873,000
-21.8%
1,793,000
+41.0%
0.08%
-9.2%
Q2 2015$61,198,0001,271,5000.09%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
AXON CAPITAL LP 216,200$9,729,00020.31%
GREAT POINT PARTNERS LLC 1,974,385$88,847,000,0009.86%
RTW INVESTMENTS, LP 3,137,361$141,181,0007.54%
Asymmetry Capital Management, L.P. 280,542$12,624,0006.84%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 259,000$11,642,0004.32%
Boxer Capital, LLC 1,000,000$45,000,0003.87%
Opaleye Management Inc. 226,388$10,187,0003.10%
SECTORAL ASSET MANAGEMENT INC 450,638$20,279,0002.42%
SCOPIA CAPITAL MANAGEMENT LP 983,005$44,235,0001.96%
Chubb Ltd 8,180$368,0001.82%
View complete list of PTC THERAPEUTICS INC shareholders